BMI Requirements: Semaglutide is generally not recommended for individuals with a BMI below 27 unless they have an obesity-related medical condition
Post Hoc Adherence Analysis As a result of the opposing results observed between semaglutide QW treatment adherence and persistence, we performed a post hoc treatment adherence analysis to test the hypothesis that the titration for semaglutide QW may have impacted the original adherence results
These effects support both type 2 diabetes management and weight loss in eligible patients
Accuracy was confirmed by recovery studies conducted at 80%, 100%, and 120% of the standard concentration
In some cases, GLP-1s seem to target the organs involved in diseases directly, making them healthier
Chen X, Cui QQ, Hu XH, Ye J, Liu ZC, Mei YX, et al